Company profile: Teckro
1.1 - Company Overview
Company description
- Provider of mobile-first clinical research technology and services, including an app for real-time data capture and study interaction; site engagement assessment with reports and insights; a communications playbook; support for study enrollment and patient retention; and tools for protocol adherence with immediate access to current protocols and expert guidance.
Products and services
- Teckro Application: A mobile-first app enabling study teams and sites to digitally engage with clinical trials via real-time data capture and interaction, instant information access, and effortless connectivity for the study team
- Protocol Adherence: Expert-guided tools that ensure investigators and site staff have immediate access to the current protocol to make informed decisions, preserving protocol consistency during clinical trial execution
- Study Enrollment: Real-time support for site staff and investigators to recruit, enroll, and retain patients by delivering immediate answers and guidance that support enrollment activities and retention in clinical studies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Teckro
RCT Logic
HQ: United States
Website
- Description: Provider of clinical trial design development and licensing for trials sponsored by industry, non-profit entities, and U.S. state governments, including the Sequential Parallel Comparison Design (SPCD) to reduce the detrimental impact of placebo response and address the placebo response problem.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RCT Logic company profile →
Thread Research
HQ: United States
Website
- Description: Provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Thread Research company profile →
Massive Bio
HQ: United States
Website
- Description: Provider of an AI-powered oncology platform that connects cancer patients to clinical trials and enables pharma to access patients. Offers SYNERGY-AI clinical trial matching, AskFiona and DrArturo AI chatbots, telehealth consultations, genomics analysis for personalized treatment, and concierge services to help patients navigate care and trial options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Massive Bio company profile →
Frontier Medicines
HQ: United States
Website
- Description: Provider of a biopharmaceutical drug discovery platform integrating chemoproteomics, covalent chemistry, and machine learning to accelerate medicine development; programs include a dual KRASG12C inhibitor (FMC-376) targeting active and inactive forms in cancers and AutoTAC for autophagy-driven targeted degradation; tools span ML/AI prioritization, chemoproteomics to identify druggable hotspots, and a covalent fragment library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontier Medicines company profile →
Inpharmatica
HQ: United Kingdom
Website
- Description: Provider of predictive informatics in medicinal chemistry and ADME to improve drug discovery, offering Chematica for target selection and druggability assessment, Silico for early ADME optimization via in silico and in vitro assessments, Admensa combining ADME expertise, tools and lab services, secreted protein therapeutics, small molecule programmes, and nicotine solutions for e‑cigarettes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inpharmatica company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Teckro
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Teckro
2.2 - Growth funds investing in similar companies to Teckro
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Teckro
4.2 - Public trading comparable groups for Teckro
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →